BR112013022438A2 - forma de dosagem de dietilestilbestrol e uso para tratamento de câncer de próstota ou de mama - Google Patents

forma de dosagem de dietilestilbestrol e uso para tratamento de câncer de próstota ou de mama

Info

Publication number
BR112013022438A2
BR112013022438A2 BR112013022438A BR112013022438A BR112013022438A2 BR 112013022438 A2 BR112013022438 A2 BR 112013022438A2 BR 112013022438 A BR112013022438 A BR 112013022438A BR 112013022438 A BR112013022438 A BR 112013022438A BR 112013022438 A2 BR112013022438 A2 BR 112013022438A2
Authority
BR
Brazil
Prior art keywords
diethylstilbestrol
dosage form
breast cancer
treating prostate
prostate
Prior art date
Application number
BR112013022438A
Other languages
English (en)
Portuguese (pt)
Inventor
Chun Kwong Chu
Diana Shu-Lian Chow
Je Phil Ryoo
Roland A Ako
Zheng Wang
Original Assignee
Nal Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nal Pharmaceuticals Ltd filed Critical Nal Pharmaceuticals Ltd
Publication of BR112013022438A2 publication Critical patent/BR112013022438A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013022438A 2011-03-03 2012-03-02 forma de dosagem de dietilestilbestrol e uso para tratamento de câncer de próstota ou de mama BR112013022438A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/040,143 US8900634B2 (en) 2008-11-03 2011-03-03 Diethylstilbestrol dosage form and methods of treatment using thereof
PCT/GB2012/050475 WO2012117257A1 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Publications (1)

Publication Number Publication Date
BR112013022438A2 true BR112013022438A2 (pt) 2016-12-06

Family

ID=45841525

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013022438A BR112013022438A2 (pt) 2011-03-03 2012-03-02 forma de dosagem de dietilestilbestrol e uso para tratamento de câncer de próstota ou de mama

Country Status (13)

Country Link
US (1) US8900634B2 (enExample)
EP (1) EP2680813B1 (enExample)
JP (2) JP6059153B2 (enExample)
KR (1) KR101865776B1 (enExample)
CN (1) CN103561720A (enExample)
AU (2) AU2012223023B2 (enExample)
BR (1) BR112013022438A2 (enExample)
CA (1) CA2827892C (enExample)
ES (1) ES2733282T3 (enExample)
RU (1) RU2602296C2 (enExample)
SG (1) SG192845A1 (enExample)
TW (1) TWI548426B (enExample)
WO (1) WO2012117257A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
BR112015008367A2 (pt) 2012-10-15 2017-07-04 Chamaeleo Pharma Bvba fosfestrol para uso no tratamento curativo ou paliativo de câncer de próstata
EP2906223A1 (en) * 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Fosfestrol for use in curative or palliative treatment of cancer in female mammals
EP2906206A1 (en) * 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Sulfestrol for treating cancer
AU2015280262B2 (en) 2014-06-24 2020-08-13 Taho Pharmaceuticals Ltd. Fast acting orally disintegrating film
CN105997857A (zh) * 2016-06-29 2016-10-12 冯志清 一种用于治疗猪乳房炎的注射液
JP2020500220A (ja) 2016-11-15 2020-01-09 クラリア ファーマ ホールディング エービー 医薬製剤
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR101940401B1 (ko) * 2017-06-12 2019-01-21 경상대학교산학협력단 맛이 차폐된 구강붕해필름 및 이의 제조방법
WO2019028457A2 (en) * 2017-08-04 2019-02-07 University Of Houston System FORMULATION OF NANOSUSPENSION OF DIETHYLSTILBESTROL INJECTABLE
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113133983B (zh) * 2020-01-20 2023-12-12 鲁南制药集团股份有限公司 一种治疗前列腺癌的药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
WO1999059544A2 (en) 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US20030147936A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Prostatic hormonal implants treatment of prostate cancer
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
WO2008045461A2 (en) 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
CA2682752C (en) * 2007-04-05 2015-07-07 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
WO2009029543A1 (en) 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof

Also Published As

Publication number Publication date
KR20140021587A (ko) 2014-02-20
ES2733282T3 (es) 2019-11-28
CA2827892C (en) 2019-12-03
CA2827892A1 (en) 2012-09-07
TW201249484A (en) 2012-12-16
SG192845A1 (en) 2013-09-30
AU2012223023B2 (en) 2017-03-16
JP2017061465A (ja) 2017-03-30
JP2014506914A (ja) 2014-03-20
KR101865776B1 (ko) 2018-06-08
US20110189288A1 (en) 2011-08-04
AU2017203009B2 (en) 2018-07-19
US8900634B2 (en) 2014-12-02
AU2017203009A1 (en) 2017-05-25
CN103561720A (zh) 2014-02-05
EP2680813B1 (en) 2019-05-08
TWI548426B (zh) 2016-09-11
JP6059153B2 (ja) 2017-01-11
EP2680813A1 (en) 2014-01-08
WO2012117257A8 (en) 2013-09-19
RU2602296C2 (ru) 2016-11-20
WO2012117257A1 (en) 2012-09-07
RU2013144383A (ru) 2015-04-10
AU2012223023A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
BR112013022438A2 (pt) forma de dosagem de dietilestilbestrol e uso para tratamento de câncer de próstota ou de mama
IL272206A (en) Combined treatment for cancer
PT2768493T (pt) Fitocanabinoides para utilização no tratamento do cancro da mama
IL264057B (en) Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasis
BR112014005080A2 (pt) métodos para o tratamento de câncer de mama
BR112014002200A2 (pt) tratamento de câncer de mama
IL245731A0 (en) Combined treatment for cancer
EP2968343A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF CANCER
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
SI3033086T1 (sl) Kombinirana terapija za zdravljenje raka
BR112014001440A2 (pt) novas composições e métodos para o tratamento de câncer de próstata
IL239007B (en) Eribulin for use in the treatment of breast cancer
HRP20190046T1 (hr) Kombinirana terapija za liječenje raka
SI2780332T1 (sl) Morfolinilbenzotriazini za uporabo pri terapiji raka
IL244353A0 (en) Compounds and use for cancer treatment
BR112012030927A2 (pt) fosfaplatinas e seu uso para o tratamento de cânceres
IL231757A (en) Antagonists ras for the treatment of malignant and non-malignant diseases
BR112013023452A2 (pt) combinação de oligonucleotídeo anti-clusterina com inibidor de hsp90 para o tratamento de câncer de próstata
BR112013028890A2 (pt) composições e métodos para o tratamento de câncer
IL238453A0 (en) Trans-clomiphene for use in cancer treatment
PL3071192T3 (pl) Związek kurkufenol do zastosowania w leczeniu nowotworu
IL227687B (en) Anti-alpha-v integrin antibody for use in the treatment of prostate cancer
FI20126281L (fi) Temotsolomidin polymeeripartikkelipohjainen annosmuoto pahanlaatuisten kasvainten hoitoon
BR112014001430A2 (pt) letalidade sintética e o tratamento do câncer
PT2780011T (pt) Terapia de combinação para cancro do ovário

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]